Ladies and gentlemen, good day and welcome to the Yatsen Second Quarter 2022 Earnings Conference Call. Today’s conference is being recorded. At this time, I would like to turn the conference over to Irene Lyu, Head of Strategic Investment and Capital Markets. Please go ahead.

Thank you, operator. Please note that discussion today will contain forward-looking statements relating to the company’s future performance and are intended to qualify for the Safe Harbor from liability as established by the U.S. Private Securities Litigation Reform Act. Such statements are not guarantees of future performance and are subject to certain risks and uncertainties, assumptions and other factors. Some of these risks are beyond the company’s control and could cause actual results to differ materially from those mentioned in today’s press release and this discussion. A general discussion of the risk factors that could affect Yatsen’s business and financial results is included in certain filings of the company with the Securities Exchange Commission. The company does not undertake any obligation to update this forward-looking information, except as required by law. During today’s call, management will also discuss certain non-GAAP financial measures for comparison purposes only. Please see the earnings release issued earlier today for a definition of non-GAAP financial measures and a reconciliation of GAAP to non-GAAP financial results. Joining us today on the call from Yatsen’s senior management team are Mr. Jinfeng Huang, our Founder, Chairman and CEO and Mr. Donghao Yang, our CFO and Director. Management will begin with prepared remarks, and the call will conclude with a Q&A session. As a reminder, this conference is being recorded. In addition, a webcast replay of this conference call will be available on Yatsen’s Investor Relations website at ir.yatsenglobal.com. I will now turn the call over to Mr. Jinfeng Huang. Please go ahead, David.

Well, thank you, Irene and thank you everyone for participating in Yatsen’s second quarter 2022 earnings conference call today. At the start of the year, we embarked our next 5 years development journey with a simple focus on building strong brands and world class R&D capabilities while achieving sustainable growth. In the second quarter, we entered into a turbulent stretch of this journey, where a confluence of challenges has put our strategies and execution to the test. The main challenge was widespread COVID-19 recurrences, which shutdown our numerous cities in China between April and June. According to the latest data from the China National Bureau of Statistics, beauty retail spending was down by 22.3% and 11% in April and May respectively before slightly recovering in June. This disproportionately impacted offline retail spending nationwide, including our offline stores. In the online arena, competition intensified as our competitors engaged in aggressive promotions to drive sales amidst sluggish market demand for color cosmetics. The premium skincare category, on the other hand, proved to be highly resilient, and in fact, grew during the second quarter. Against this backdrop, our total net revenue decreased by 37.6% year-over-year to RMB951.8 million, meeting the high-end of our revenue guidance. The year-over-year decline in revenues was mainly due to soft performance of our color cosmetics brand, particularly offset – partially offset by stellar growth across our skincare brands. Our non-GAAP net loss margin reached 20.8% in the second quarter, an increase of 9 percentage points compared with the prior year period, attributable to the higher operating cost ratios of our offline stores due to weak offline store sales as well as inventory loss and provisions for store closures. Encouragingly, our quarterly net cash generated from operating activities turned positive for the first time since Yatsen’s IPO at RMB111.9…

Thank you, David, and hello, everyone. Before I get started, I would like to clarify that all financial numbers presented today are in renminbi amounts, and all percentage changes refer to year-over-year changes unless otherwise noted. Total net revenues for the second quarter of 2022 decreased by 37.6% to RMB951.8 million from RMB1.53 billion in the prior year period. The decrease was primarily attributable to 50.5% decline in net revenues from our color cosmetics brands, partially offset by a 49.2% increase in net revenues from our skincare brands. Gross profit for the second quarter of 2022 decreased by 40.3% to RMB598.3 million from RMB1 billion in the prior year period. Gross margin for the second quarter of 2022 decreased to 62.9% from 65.7% in the prior year period. The decrease was primarily attributable to elevated levels of promotions during the June 18 shopping festival and an inventory loss of RMB43.9 million. Total operating expenses for the second quarter of 2022 decreased by 38% to RMB875.3 million from RMB1.41 billion in the prior year period. As a percentage of total net revenues, total operating expenses for the second quarter of 2022 were 92% as compared with 92.6% in the prior year period. Fulfillment expenses for the second quarter of 2022 were RMB69.7 million as compared with RMB118.1 million in the prior year period. As a percentage of total net revenue, fulfillment expenses for the second quarter of 2022 decreased to 7.3% from 7.7% in the prior year period. The decrease was primarily attributable to a reduction in share-based compensation corresponding to a decrease in fulfillment head count. Selling and marketing expenses for the second quarter of 2022 were RMB625.7 million as compared with RMB972.5 million in the prior year period. As a percentage of total net revenues, selling and marketing expenses…

Thank you. [Operator Instructions] Today’s first question comes from Dustin Wei of Morgan Stanley. Please go ahead.

Thanks a lot for taking my questions. The first question, I want to start with the guidance. The third quarter guidance in terms of the revenue, the decline magnitude, is quite similar to the second quarter. But considering, I think, the COVID situation probably is worse is over, and I think the base will be also lower into the second half and the third quarter. So I understand that, Donghao talk about the softness in color cosmetics, but just wondering if there’s more information behind this guidance? And maybe management could share some of the near-term trend third quarter today, and maybe by channel or by products or by category, what kind of softness that we are talking about? And second question regarding the GP margin. So I think this is probably the second quarter that we have this inventory loss or the inventory provision, so I’m not sure if we have this number to share regarding the inventory age structure. Like, how much sort of a little bit aging inventory that we’re still seeing that can potentially still be written off in the coming quarters? And also regarding GP margin, I think it’s encouraging to see the revenue contribution from the skincare is increasing. And so I think it’s probably on the direction to reach to almost like half of the business coming from skincare. So how should we in longer-term or maybe next year or so, think about the GP margin for the company? Thank you.

Alright. Thanks for the question. First on guidance. Wei, the overall cosmetics market in China has experienced a very sharp decline starting from the – at beginning of this year. While some of that actually was related to macro economy, the global situation, and some of that also was due to the COVID-19 situation, especially in Shanghai and areas around Shanghai. Even today, you may also know that in a lot of the areas, regions in China, the COVID-19 situation is still very serious. For example, today, I think in some of the Northwest and Southwest provinces in China, people are still restricted from traveling due to the resurgence of the COVID-19 pandemic. So, that’s about the overall market softness that we have experienced this year. And if you compare our Q3 guidance versus Q2, and you have mentioned, our Q3 guidance is very similar to the level of Q2. Actually, to us, we view that as a very positive signal. That means the business has stabilized from the trend of a sharp decline starting from the beginning of this year, and so that’s one thing. Our overall business is stabilizing. And also, the softness of our color cosmetics business is, to some extent, offset by our strong growth in skincare. So, that’s why we are giving this guidance level similar to that of Q2. And you talked about our GP margin and aging of the inventory. We are not providing that kind of the details for our inventory, but we can tell you – what we can tell you is we made a provision of RMB44 million for obsolete inventory in Q2, which is quite a substantial number. And we do have a provision policy as part of our overall accounting policy. And going forward, we will continue to make provisions as required by our policy. David, Irene, do you have anything else to add?

Yes. Sure. So, yes, on the guidance, basically, I think it’s – we are providing this based on our estimation on both the external and internal factors. And then we have to look at it by different product category, right. For example, on the color cosmetics side, Donghao has mentioned external environment with the resurgence of the COVID, which continues to impact consumer confidence, and also the unemployment rate among the young generation these days are also impacted by the COVID situation, which those people are our core customers. So, that continues to impact the color cosmetic market, which we could also see in the July beauty – overall, China beauty retail spending is still negative growth year-over-year. That’s on the external side for color. And internally, as we are still going through our strategic evolution, we are still really focusing on high-quality revenue for those color cosmetics brands. So, right now, because of this refining of our business model, we could still see a decline in the color cosmetics segment of our business. And on the skincare side, we had a very strong growth in Q2. And for skincare, because it’s highly seasonal, right. Normally, Q2 and Q4 are the major season for skincare because consumers tend to stock up during large promotions. So, for Q3, we think we continue, we will see growth in skincare. But given it’s kind of a quiet period for the e-commerce sales, that’s why we are also providing this guidance. That’s kind of just some additional points on the guidance side.

Yes. One other thing to add, you just asked about the impact of our – the growth of our skincare business on the gross margin trend. And obviously, our skincare business, has much higher gross margin level than our color cosmetics, so the difference could be as big as like 10 percentage points. So, as we continue to grow our skincare business – as the skincare business continues to take more shares in our total product mix, we believe that the – we will continue to see improvement on our gross margin.

Alright. Got it. Thanks a lot.

Thank you.

Ladies and gentlemen, our next question comes from Kian Lin [ph] with CICC.

Thanks for taking my questions. I have two questions. The first one regarding selling and marketing expenses, as industry competition intensifying and some international brands also lowered their price, which exerts great pressure to color cosmetic brands. So, could the management give some color on your plans for marketing and promotion in the second half of 2022? And how do you see the channel of – selling and the marketing expenses as a percentage of total revenue in the second half of the year? And the second question regarding organizational structure. As the growth offsets brand portfolio, could you give some color on how you allocate resources and talent among different brands?

Well, thank you very much for your question. First, on the selling and marketing, we compete, of course, with other overseas brands and as well as our domestic – those domestic brands. Not only on selling and marketing, but also we are making very big investments in our R&D capabilities. We wanted to improve the efficacy of our products to make it one of our biggest competitive advantages going forward. So, for the second half of this year, I believe the selling and marketing expenses as a percent of revenue will most likely stay at a relatively stable level, meaning you won’t be seeing a sharp increase in our selling and marketing expenses to drive sales growth. Because we – for the long-term, we do believe that the product efficacy and our investment in R&D will be the most important drivers of our future business growth. And organization structure, how do we allocate our talent, well, it depends. For our skincare brand, I think we will allocate or we will assign our talent in marketing and branding most likely to those brands. And R&D, we are going to allocate more R&D dollars for talents for our skincare brands. And for color cosmetics, maybe more operational, and also branding is also very important. So, it really depends on the specific brand and market segments and product categories, and etcetera.

Got it. Thank you very much. I have no other question.

Thank you.

[Operator Instructions] Today’s next question comes from Olivia Tong with Raymond James. Please go ahead.

Hi. This is Devin Weinstein on for Olivia. I appreciate you taking our questions. First, I just wanted to ask a little bit more about the competition that you are experiencing. One, how would you compare it to prior quarters, and perhaps how are you looking at it going ahead? And then I want to specifically ask about the level of promotional activity that you experienced during the 6/18 event, and how you are expecting it to evolve for 11/11, and any preparations that you are making for that?

Yes, sure. So, most of the competitors – public listed companies have reported their Q2 as well, we are seeing [ph] a soft season for most of the competitors, so which is kind of demonstrating our thesis on the overall demand, but the beauty industry in China has been impacted by the ongoing COVID and also consumer confidence issue. The competition is still quite enhanced. Ever since last year, we are actually at the beginning of the COVID, where there is more pressure for the international players there to meet their targets. So, their sales and promotions have been strong, which is still the case. Going forward, we think as COVID, if after this year could become more of – we will pass COVID, then such level of promotions we think would ease in the future. So, that’s angle number one. And then secondly, nowadays, it’s not only competition based on promotions, right, and also not only on branding, but more, as Donghao mentioned, on efficacy of the product. We are seeing, for example, recently, some of international companies reported their financials, some strong, some not strong. And you can see because of the difference of efficacy of its products, right, especially for skincare, if the brand portfolio has brands which more focusing on efficacy-based products, then the performance tends to be stronger in the Chinese market because these days, consumers and KOLs are more sophisticated in terms of formulation ingredients. So, we think, as we mentioned, the three of the recently-acquired skincare brands, right, in the efficacious and also premium category, the Eve Lom, Galénic and DR. WU, are – the growth is over 100% for Q2, which we think because of the position of varying trend in China, we will continue to see a strong growth of those brands.

Thank you. Appreciate that. And if I could just sneak in one more. I just wanted to ask, I realized the shutdowns and the lockdowns from COVID impacted you. Was there any material impact from Hainan on your business?

So, just wanted to clarify, you mean the duty-free of the Hainan sales, right, given the recent closure of Hainan shops?

Correct. I was curious what impact that is having on your business, that area specifically.

Yes. It’s relatively small for us because only premium and luxury skincare only have large distribution in Hainan. We do have distribution of Eve Lom in Hainan right now, but still a relatively small contribution to the overall revenue as most of our businesses are still in the mass and mid-end segment.

Okay. Very helpful. Thank you so much for squeezing me in.

Thank you.

[Operator Instructions] And everyone, this concludes our question-and-answer session. I would like to turn the conference back over to management for any additional or closing remarks.

Great. Thank you once again for joining us today. If you have any further questions, please feel free to contact us at Yatsen directly or TPG Investor Relations. Our contact information for IR in both China and the U.S. can be found in today’s press release. Thank you. Have a great day.

Thank you. This concludes today’s conference call. We thank you all for attending today’s presentation. You may now disconnect your lines and have a wonderful day.